Inventor · disambiguated record
Ilana Mandel
Also filed as: MANDEL ILANA
11 granted patents·13 pending applications·24 citations·filing 2012–2025
86Inventor score
Files withBIOND BIOLOGICS LTD16FAMEWAVE LTD4CCAM BIOTHERAPEUTICS LTD3TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD1
Top patents by PatentIndex Score
24 records- 0188US11866509B2Humanized antibodies against CEACAM1FAMEWAVE LTD·Filed 2020·Granted Jan 9, 2024·2 cites·18 claims
- 0288US11236162B2Antibodies against ILT2BIOND BIOLOGICS LTD·Filed 2021·Granted Feb 1, 2022·2 cites·14 claims
- 0382US9771431B2Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM)TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD·Filed 2012·Granted Sep 26, 2017·5 cites·19 claims
- 0481US10081679B2Compositions comprising anti-CEACAM1 and anti-PD antibodies for cancer therapyCCAM BIOTHERAPEUTICS LTD·Filed 2014·Granted Sep 25, 2018·10 cites·18 claims
- 0580US12071479B2Antibodies against ILT2 and use thereofBIOND BIOLOGICS LTD·Filed 2021·Granted Aug 27, 2024·1 cites·23 claims
- 0678US10550196B2Humanized antibodies against CEACAM1CCAM BIOTHERAPEUTICS LTD·Filed 2015·Granted Feb 4, 2020·3 cites·16 claims
- 0777US12139534B2Methods and compositions for decreasing soluble immune receptor CD28BIOND BIOLOGICS LTD·Filed 2019·Granted Nov 12, 2024·1 cites·10 claims
- 0876US2024309094A1Methods and compositions for decreasing soluble immune receptor cd28BIOND BIOLOGICS LTD·Filed 2024·Application pending·0 cites
- 0975US2025388668A1Antibodies against ilt2 and use thereofBIOND BIOLOGICS LTD·Filed 2025·Application pending·0 cites
- 1069US12391755B2Methods of use for anti-ILT2 antibodiesBIOND BIOLOGICS LTD·Filed 2021·Granted Aug 19, 2025·0 cites·20 claims
- 1167US11891453B2Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM)FAMEWAVE LTD·Filed 2020·Granted Feb 6, 2024·0 cites·20 claims
- 1262US2024092934A1Assessment of ceacam1 expression on tumor infiltrating lymphocytesFAMEWAVE LTD·Filed 2023·Application pending·0 cites
- 1361US2025019441A1Treatment of cancer with anti-ilt2 antibodiesBIOND BIOLOGICS LTD·Filed 2024·Application pending·0 cites
- 1459US2025277032A1Anti-ilt3 antibodies and use thereofBIOND BIOLOGICS LTD·Filed 2023·Application pending·0 cites
- 1558US2023221325A1Soluble cd28 levels after immunotherapyBIOND BIOLOGICS LTD·Filed 2023·Application pending·0 cites
- 1657US11427647B2Polynucleotides encoding humanized antibodies against CEACAM1FAMEWAVE LTD·Filed 2019·Granted Aug 30, 2022·0 cites·19 claims
- 1757US2024350648A1Intracellular delivery compositionsBIOND BIOLOGICS LTD·Filed 2024·Application pending·0 cites
- 1856US2024279335A1Cd28 shedding blocking agentsBIOND BIOLOGICS LTD·Filed 2022·Application pending·0 cites
- 1951US2024010706A1Immunomodulatory compostions and use thereofBIOND BIOLOGICS LTD·Filed 2021·Application pending·0 cites
- 2049US2017355781A1Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)CCAM BIOTHERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 2148US2023035730A1Soluble cd28 levels during immunotherapyBIOND BIOLOGICS LTD·Filed 2020·Application pending·0 cites
- 2248US2023041599A1Use of mmp inhibitionBIOND BIOLOGICS LTD·Filed 2020·Application pending·0 cites
- 2347US12503510B2Small shedding blocking agentsBIOND BIOLOGICS LTD·Filed 2020·Granted Dec 23, 2025·0 cites·20 claims
- 2446US2022153845A1A method for immunosuppressionBIOND BIOLOGICS LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ilana Mandel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →